Clinical trial
Hemostatic Effects of VELCADE®* Treatment in Multiple Myeloma Patients
NCT01720043 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hemostatic Effects of VELCADE®* Treatment in Multiple Myeloma Patients
- Lead sponsor
- University of Utah
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 31, 2013
- Completion date
- July 31, 2017
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.